Corticosteroids and / or Arthrographic Distention in the Treatment of Adhesive Capsulitis (CADAC)
Adhesive Capsulitis, Frozen Shoulder
About this trial
This is an interventional treatment trial for Adhesive Capsulitis focused on measuring Arthrographic distention, Hydrodilatation, Intra-articular corticosteroid injection
Eligibility Criteria
Inclusion Criteria:
- Pain and stiffness in predominantly 1 shoulder for 4 weeks or longer
- Restriction of passive motion of greater than 30° in 2 or more planes of movement (measured to onset of pain with goniometer)
Exclusion Criteria:
- Previous arthrographic distention and/or corticosteroid injection
- Systemic inflammatory joint disease
- Radiological evidence of osteoarthritis of the shoulder or fracture
- Signs of a complete rotator cuff tear
- Contraindications to arthrogram and/or distention
- Lack of written informed consent
Sites / Locations
- Imelda Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
Active Comparator
Arthrographic distention + intra-articular corticosteroid
Arthrographic distention
Intra-articular corticosteroid
Arthrographic distention of the glenohumeral joint with injection of 5 ml contrast, 1 ml (40 mg) Depo Medrol(Methylprednisolone Acetate Injectable Suspension), 15 ml local anaesthetic (Prilocaine) and up to 15 ml saline.
Arthrographic distention of the glenohumeral joint with injection of 5 ml contrast, 15 ml local anaesthetic (Prilocaine) and up to 15 ml saline.
Arthrographic pseudodistention of the glenohumeral joint with injection of 5 ml contrast and 1 ml (40 mg) Depo Medrol(Methylprednisolone Acetate Injectable Suspension).